Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
about
Adipose tissue, obesity and adipokines: role in cancer promotionMetabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cellsFunctional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levelsEffects of age on the synergistic interactions between lipopolysaccharide and mechanical ventilation in mice.Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohortIncreased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.2D-DIGE as a strategy to identify serum biomarkers in Mexican patients with Type-2 diabetes with different body mass index.Adipokines NUCB2/nesfatin-1 and visfatin as novel inflammatory factors in chronic obstructive pulmonary disease.Serum adipokines in inflammatory bowel disease.Elevated serum levels of visfatin in patients with henoch-schönlein purpura.Visfatin induces sickness responses in the brain.Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.Compartmentation of NAD+-dependent signalling.Characterization and function of histamine receptors in human bone marrow stromal cells.Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury.Characterization of the Human Adipocyte Proteome and Reproducibility of Protein Abundance by One-Dimensional Gel Electrophoresis and HPLC-ESI-MS/MS.Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation.Neuropeptides, growth factors, and cytokines: a cohort of informational molecules whose expression is up-regulated by the stress-associated slow transmitter PACAP in chromaffin cellsEffect of periodontal treatment on adipokines in type 2 diabetes.Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular disease.Adipocytokine profile, cytokine levels and foxp3 expression in multiple sclerosis: a possible link to susceptibility and clinical course of disease.Plasma levels of leptin and visfatin in rheumatoid arthritis patients; is there any relationship with joint damage?Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism.Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages.Comparison of particle-exposure triggered pulmonary and systemic inflammation in mice fed with three different dietsEffect of Non-surgical Periodontal Therapy on Serum and Salivary Concentrations of Visfatin in Patients with Chronic PeriodontitisNicotinamide Phosphoribosyltransferase in Human Diseases.Salivary Visfatin Concentration in Response to Non-surgical Periodontal Therapy.Pre-B-cell colony-enhancing factor exerts a neuronal protection through its enzymatic activity and the reduction of mitochondrial dysfunction in in vitro ischemic models.Expression of SDF-1α and leptin, and their effect on expression of angiogenic factors in mouse ovaries.Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis.Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis.Value of adipokines in predicting the severity of acute pancreatitis: comprehensive review.Circulating Visfatin in Hypothyroidism Is Associated with Free Thyroid Hormones and Antithyroperoxidase Antibodies.Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarctionPharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.Current trends in inflammatory and immunomodulatory mediators in sepsisElevated plasma level of visfatin/pre-b cell colony-enhancing factor in male oral squamous cell carcinoma patients.
P2860
Q28086997-F1569795-B1D9-459D-BD38-34386DA7413CQ28542558-F0C20872-4FDC-490D-87DF-87FFCB15B26CQ28729063-B3E4CBD7-E26C-4FE6-B279-C42B0A334B01Q30496915-8A4D3A3C-0F82-45B6-9E43-6771772BCDA6Q30839061-0310C091-B9E4-4E98-AA7B-74DA2F1C7FC0Q33431469-98FA05C8-34FF-4421-9729-E7C3643D8E64Q33582700-B22EF40A-BEFA-4DA7-BCAA-DB7A7D365F5FQ33660762-14312212-42A8-419B-A26B-BFD17142C5D5Q33735303-26167717-942C-4565-AB29-049D30813F47Q33801961-49429CF8-027F-4381-9E68-E897BEBAFDDBQ33809413-08E06F7F-80A6-4034-9D40-8D43D01F8898Q33950766-C8FD07C4-38BD-488D-A13F-EC972F51D1DBQ34021686-B2CFFD39-8B09-4413-89C7-659816210028Q34026322-5889DCE7-91B4-49CA-8AFD-B6CF52B25AB4Q34066174-A89E1715-704F-4635-9097-4ADB9EDDC0B6Q34103687-8AC4E056-58C4-4EAE-AA61-E9AB69B149AFQ34109923-46B0E90E-C49E-4A22-B533-3C3D374C271DQ34235614-8206D3DF-D749-4AFD-9556-F3C01EFBEE60Q34280473-3C257751-15CC-44B1-AA2F-3F8880E8A7BDQ34699263-81C076F3-A566-483C-B753-3E9120905F29Q34929150-34D379A4-7424-42B7-8045-6128CBAAADEAQ35009543-C86F164E-4F8A-4CB6-87C7-9FC7FCC528F5Q35065164-3256D8F4-A329-46A3-83FA-31E8A827EB43Q35083117-DAA80F45-7CCF-4FE0-8F6D-DD77C21FB28FQ35244183-4526EFC7-3FE3-4A92-BDF3-4BF86830F481Q35397319-23D3D5AC-33B6-4165-980E-ABF0FBF62E51Q35563179-3D1E2724-B155-4DAF-88D5-A67473ABE79DQ35581515-C0109170-82B4-4C3A-956C-834B9564300CQ35622901-CA26A2B7-9A0D-41F0-955C-A3D1BE7F4CA0Q35626960-8C63CDAC-2BA0-400F-88F1-D8625C6939DDQ35767839-1F4DDED0-3936-4541-9840-5603C7B4BAFEQ35860727-BB9B02D1-06D8-41FB-8283-9E9B66B9854FQ35876759-79A7A40E-3C74-49C0-B3FA-5FD938950A30Q36283981-9148A23A-FBAB-4596-987A-F7466C0A431FQ36450509-D0372000-A5C4-4386-8FB8-FA666A684F20Q36538245-64579976-5746-4505-B17F-F30338848E5FQ36545914-9E653B1A-39BE-4EA3-9D04-0C22532021A4Q36579595-DD9A3F4B-F03C-4B49-A855-3D8E3C5869CCQ36628592-7F3F1923-17CF-42E0-90CF-454D33868FE7Q36733307-0BAFA452-F4A1-4D27-BCA4-D15445005DE6
P2860
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
@en
Pre-B cell colony-enhancing factor
@nl
type
label
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
@en
Pre-B cell colony-enhancing factor
@nl
prefLabel
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
@en
Pre-B cell colony-enhancing factor
@nl
P2093
P356
P1476
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
@en
P2093
John C Marshall
Zeenat Malam
P304
P356
10.1189/JLB.0807581
P577
2008-02-05T00:00:00Z